[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340567-105":3,"doc-detail-340567-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ednra-regulates-the-tumour-immune-environment-and-predicts-the-efficacy-and-prognosis-of-cancer-immunotherapy","EDNRA regulates the tumour immune environment and predicts the efficacy and prognosis of cancer immunotherapy","","Endothelin receptor A (EDNRA) has been implicated in cancer immunotherapy, yet its therapeutic mechanism and clinical relevance require clarification. Clinical characteristics and gene-expression data from the Cancer Genome Atlas were integrated to examine EDNRA expression patterns and immune infiltration relationships using TIMER and TISIDB. EDNRA expression across cancer types was evaluated by qPCR, while immunohistochemistry assessed links between EDNRA protein and immune checkpoints. Results indicate EDNRA is differentially expressed, associated with age and tumour stage, and predicts patient survival. Low EDNRA levels correlate with superior immunotherapy response. Mechanistic work suggests EDNRA promotes proliferation and migration, supporting EDNRA as a potential immunotherapy target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ednra-regulates-the-tumour-immune-environment-and-predicts-the-efficacy-and-prognosis-of-cancer-immunotherapy/340567/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ednra-regulates-the-tumour-immune-environment-and-predicts-the-efficacy-and-prognosis-of-cancer-immunotherapy/340567.png","ImageObject",300,407,{"name":42,"@type":43},"Evangeline","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the study’s main goal regarding EDNRA and immunotherapy?","Question",{"text":63,"@type":64},"To clarify the potential link between cancer immunotherapy and EDNRA in human tumours, including its mechanism and clinical implications for treatment efficacy and prognosis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which databases and experimental methods were used to evaluate EDNRA?",{"text":68,"@type":64},"Clinical characteristics and gene-expression information were obtained from The Cancer Genome Atlas, correlations with immune infiltration were analyzed with TIMER and TISIDB, expression was assessed by qPCR, and EDNRA protein relationships with immune checkpoints were measured by immunohistochemistry.",{"name":70,"@type":61,"acceptedAnswer":71},"How is EDNRA related to patient outcomes and immunotherapy response?",{"text":72,"@type":64},"EDNRA was differentially expressed across tumours, associated with age and tumour stage, and showed prognostic value for survival. Patients with low EDNRA levels demonstrated a superior response to immunotherapy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340567,1790182363,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188",8,"DOI: 10. 1111/jcmm.70172  \nOR I G I NAL ART I C L E  \nEDNRA regulates the tumour immune environment and  \npredicts the efficacy and prognosis of cancer immunotherapy  \nMengxue Wang1 | Long Wang2 | Xunjia Li3 | Meng Dai4 | Bo Sheng1   \n1Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China  \n2Department of Breast Cancer Center, Chongqing University Cancer Hospital, Chongqing, China  \n3 Department of Nephrology, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China  \n4Department of oncology, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China  \nCorrespondence  \nBo Sheng, Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.  \nEmail: [306188@hospital.cqmu.edu.cn](306188@hospital.cqmu.edu.cn)  \nFunding information  \nthe Project of Chongqing Education Commission Science and Technology Foundation, Grant/Award Number:  \nCSTB2023NSCQ-BHX0090  \nAbstract  \nThe potential role of endothelin receptor A (EDNRA) in cancer immunotherapy has been demonstrated; however, the mechanism of its therapeutic value remains to be investigated. This study aimed to reveal the potential link between cancer immunotherapy and EDNRA in human tumours. Clinical characteristics and gene expression information were acquired from the Cancer Genome Atlas database. The correlation between EDNRA expression and immune infiltration was analysed by tumour immune estimation resource (TIMER) and tumour-immune system interaction database (TISIDB) . EDNRA expression in different cancer types were performed via qPCR. Immunohistochemistry was used to detect the relationships between EDNRA protein and immune checkpoints. The results have founded that EDNRA was differentially expressed in various tumours, and highly associated with patient's age and tumour stage. It is also of high potential prognostic value in predicting patient survival. It has been verified that the EDNRA, JAK–STAT, and TGF-β signalling pathways are involved in cancers. In general, EDNRA positively correlated with immunomodulatory agents, immune cell infiltration, and immunotherapy markers. Immunohistochemical analysis of breast cancer tissues showed that EDNRA was positively correlated with NRP1 expression. Furthermore, patients with low EDNRA levels showed a superior response to immunotherapy. The functional study found that EDNRA expression is upregulated in MDA-MB-231 and HepG2 cells, and knockdown of EDNRA inhibits proliferation and migration of cells. In conclusion, the immunotherapeutic function of EDNRA was elucidated in this study. EDNRA may be an important target in tumour immunotherapy and provide new insights for tumour immunotherapy.  \nK E Y WO R D S  \nendothelin receptor a, immunotherapy, immunotherapy response, pan-cancer, prognosis  \n1 | INTRODUCTION  \nEndothelin-1, an endothelin receptor A (EDNRA), a guanine nucleotide-binding protein, is widely expressed in humans.  \nEDNRA encodes the endothelin-1 (ET-1) receptor, a peptide primarily discovered in the vascular smooth muscle that plays a role in vasoconstriction and cell proliferation.1–3 It has been reported that EDNRA is highly associated with many diseases, including  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Author(s) . Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.  \nJ Cell Mol Med. 2024;28:e70172 .  \n[https://doi.org/10.1111/jcmm.70172](https://doi.org/10.1111/jcmm.70172)  \n[wileyonlinelibrary.com/journal/jcmm](wileyonlinelibrary.com/journal/jcmm)  \n1 of 14  \nmassive atherosclerotic stroke, intracranial aneurysm, mandibular hypoplasia with alopecia,4,5 and migraine with or without aura. Moreover, EDNRA plays an active role i","cbCait4ILDlm2zy9","https://ap.wps.com/l/cbCait4ILDlm2zy9","pdf",29408610,14,"English","# Abstract\n# Introduction\n## EDNRA background and disease associations\n## EDNRA in tumors and immune microenvironment","[{\"question\":\"What was the study’s main goal regarding EDNRA and immunotherapy?\",\"answer\":\"To clarify the potential link between cancer immunotherapy and EDNRA in human tumours, including its mechanism and clinical implications for treatment efficacy and prognosis.\"},{\"question\":\"Which databases and experimental methods were used to evaluate EDNRA?\",\"answer\":\"Clinical characteristics and gene-expression information were obtained from The Cancer Genome Atlas, correlations with immune infiltration were analyzed with TIMER and TISIDB, expression was assessed by qPCR, and EDNRA protein relationships with immune checkpoints were measured by immunohistochemistry.\"},{\"question\":\"How is EDNRA related to patient outcomes and immunotherapy response?\",\"answer\":\"EDNRA was differentially expressed across tumours, associated with age and tumour stage, and showed prognostic value for survival. Patients with low EDNRA levels demonstrated a superior response to immunotherapy.\"}]","EDNRA regulates the tumour immune environment and predicts the efficacy and prognosis of cancer immunotherapy | PDF",1790037384,35,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d89431dbec89ac7ff6a6a057022f049.webp",983,1291,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f7cd1249b2eaf633ce7bab51224e109.webp",982,1290,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cdf1fccd8ba13c9a90ec6fb726096387.webp",981,1289,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/288c8ff4ec7ef2d1f94a79328f3d0251.webp",980,1287,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,145,148,153,156,160],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":141,"doc_module":4,"doc_module_name":25,"category_name":142,"show_sort_weight":143,"slug":144},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":146,"slug":147},30,"research-report",{"id":149,"doc_module":4,"doc_module_name":25,"category_name":150,"show_sort_weight":151,"slug":152},9,"Religion & Spirituality",20,"religion-spirituality",{"id":151,"doc_module":4,"doc_module_name":25,"category_name":154,"show_sort_weight":151,"slug":155},"World Cup","world-cup",{"id":157,"doc_module":4,"doc_module_name":25,"category_name":158,"show_sort_weight":157,"slug":159},10,"Lifestyle","lifestyle",{"id":161,"doc_module":4,"doc_module_name":25,"category_name":162,"show_sort_weight":131,"slug":163},19,"General","general"]